CTRI/2021/08/035342
Completed
未知
Pleiotropic effects of Teneligliptin versus Glimepiride as add on therapy to Metformin on Inflammatory biomarker hsCRP and Insulin resistance : An open-labelled randomized controlled trial
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: E119- Type 2 diabetes mellitus without complications
- Sponsor
- All India Institute of Medical Sciences Rishikesh
- Enrollment
- 70
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Type 2 Diabetes patients not controlled by Metformin alone (with HbA1C \> 7% )
- •Age \> 20 years and \< 60 years
- •Both male and female gendersÂ
Exclusion Criteria
- •Type 2 Diabetes patients who are already on any DPP4 inhibitors \& Metformin combination therapy or on Insulin or any other incretin based therapy or any hypoglycaemic agents
- •Patients with any acute inflammatory/ infective condition with CRP \> 10 mg/L and any history of acute infection/ inflammation in past 3 monthsÂ
- •Patients with chronic inflammatory conditions, autoimmune diseases, Neoplasia
- •Patients with serious macrovascular complications such as acute MI, angina or stroke within six months of enrolment
- •Type 1 Diabetes patients or any other form of diabetes
- •Pregnant or Breastfeeding females
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Study of antidiabetic drugs on markers of inflammation in type 2 diabetes mellitus patients.CTRI/2018/03/012603MALEHA BUT
Completed
Not Applicable
The examination of the effects of Teneligliptin on blood glucose and albuminuria in type 2 diabetic patients with nephropathy, whose glycemic control is insufficient.Type 2 diabetic patients with nephropathyJPRN-UMIN000015922Kanazawa Medical University50
Completed
Not Applicable
The efficacy of teneligliptin in patients with type 2 diabetes mellitusJPRN-UMIN000028763Juntendo University Urayasu Hospital30
Recruiting
Not Applicable
A study to understand the combined effect of sitagliptin and teneligliptin with metformin in comparison to metformin alone treatment on blood glucose cotrol in patients with type 2 diabetes mellitus.Health Condition 1: null- Type 2 Diabetes MellitusCTRI/2018/03/012413Department of Pharmacology and Therapeutics
Completed
Not Applicable
Comparison of efficacy of Teneligliptin and Sitagliptin for glucose fluctuation in Type 2 diabetesType 2 diabetesJPRN-UMIN000022885niversity of Occupational and Environmental Health, Japan, First Department of Internal Medicine, School of Medicine20